|1||Active, not recruiting||
Safety Study of PLX4032 in Patients With Solid Tumors
Matching Patients With Hematologic Malignancy to Adequate Clinical Trials
Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
† Study has passed its completion date and status has not been verified in more than two years.